Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,582.69
(
0.11%
)
US TECH 100
23,514.00
(
0.49%
)
Dow Jones
46,504.67
(
-0.13%
)
Brent Oil
105.71
(
-3.17%
)
Bitcoin
69,821.23
(
1.18%
)
News Focus
News Focus
Post# of 11383
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fred Kadiddlehopper

Send PM Follow Ignore
Followers 28
Posts 4989
Boards Moderated 0
Alias Born 09/22/2006

Fred Kadiddlehopper

Re: None

Wednesday, 03/18/2020 7:30:47 AM

Wednesday, March 18, 2020 7:30:47 AM

Post# of 11383
Charles Duncan of Cantor: HALO PT: $35. Says Daratumumab due for approval in mid 2020 and that herceptin/perjeta approval in later 2020 is "underappreciated".

The more you know, the less you don't know.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News